FCSC News and Press, Fibrocell Science Inc. From 09/13/19

Mer Telemanagement Solutions (NASDAQ: MTSL ) +96%  on 1H results . More news on: Mer Telemanagement Solutions Ltd., Fibrocell Science, Inc., Cellectar Biosciences, Inc., Stocks on the move, Read more ...

PARSIPPANY, N.J. , Sept. 12, 2019 /PRNewswire/ -- Castle Creek Pharmaceutical Holdings, Inc. ("CCP Holdings") today announced it has reached an agreement to acquire Fibrocell Science, Inc. (Nasdaq: FCSC), a cell and gene therapy company focused on transformational autologous cell-bas...

- Total consideration of $ 63.3 million, including repayment of debt and other financial instruments - - Acquisition expected to close in the fourth quarter of 2019 - - Further strengthens Castle Creek Pharmaceuticals as a leader in dermatology - EXTON, Pa., Sept. 12, 2019 (GL...

The FDA approves  privately held Boehringer Ingelheim's Ofev (nintedanib) to slow the rate of decline in pulmonary function in adult patients with interstitial lung disease associated with systemic sclerosis , a rare disorder of unknown cause characterized by diffuse scarring and va...

Fibrocell Science (NASDAQ: FCSC ) Q2 results : More news on: Fibrocell Science, Inc., Healthcare stocks news, Stocks on the move, Read more ...

Fibrocell Science (NASDAQ: FCSC ): Q2 EPS of $1.12 may not be comparable to consensus of -$0.18. More news on: Fibrocell Science, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

- Company to Host Conference Call and Webcast on Thursday, August 15 at 8:30 a.m. EDT - EXTON, Pa., Aug. 14, 2019 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (Nasdaq: FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissu...

EXTON, Pa., May 30, 2019 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (Nasdaq: FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today announced that John Maslowski, President and Chief Executive Officer, will p...

Eltek (NASDAQ: ELTK ) +79%  on Q1 earnings . More news on: Eltek Ltd., Soliton, Inc., ReWalk Robotics Ltd., Stocks on the move, Read more ...

Nano cap Fibrocell Science (NASDAQ: FCSC ) is up  17%  premarket on increased volume in reaction to the FDA's designation of Regenerative Medicine Advanced Therapy (RMAT) status for gene therapy FCX-007 for the treatment of a rare inherited skin disorder called recessive dys...